 | • レポートコード：MRC2312MG03171 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の前臨床毒性試験サービス市場規模と予測を収録しています。・世界の前臨床毒性試験サービス市場：売上、2018年-2023年、2024年-2029年 ・世界の前臨床毒性試験サービス市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の前臨床毒性試験サービス市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「In Vitro毒性試験」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 前臨床毒性試験サービスのグローバル主要企業は、Agilent、 Abbott、 Bio-Rad、 Scantox、 Charles River、 Bioreliance、 Catalent、 INVITEK Inc.、 Altogen Labs、 Pacific BioLabs、 AmplifyBio、 Altasciences、 Evotec、 Eurofins Scientific、 Pharmaronなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、前臨床毒性試験サービスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の前臨床毒性試験サービス市場：タイプ別、2018年-2023年、2024年-2029年 世界の前臨床毒性試験サービス市場：タイプ別市場シェア、2022年 ・In Vitro毒性試験、In Vivo毒性試験 世界の前臨床毒性試験サービス市場：用途別、2018年-2023年、2024年-2029年 世界の前臨床毒性試験サービス市場：用途別市場シェア、2022年 ・バイオ製薬会社、研究所、その他 世界の前臨床毒性試験サービス市場：地域・国別、2018年-2023年、2024年-2029年 世界の前臨床毒性試験サービス市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における前臨床毒性試験サービスのグローバル売上、2018年-2023年 ・主要企業における前臨床毒性試験サービスのグローバル売上シェア、2022年 ・主要企業における前臨床毒性試験サービスのグローバル販売量、2018年-2023年 ・主要企業における前臨床毒性試験サービスのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Agilent、 Abbott、 Bio-Rad、 Scantox、 Charles River、 Bioreliance、 Catalent、 INVITEK Inc.、 Altogen Labs、 Pacific BioLabs、 AmplifyBio、 Altasciences、 Evotec、 Eurofins Scientific、 Pharmaron ************************************************************* ・調査・分析レポートの概要 前臨床毒性試験サービス市場の定義 市場セグメント 世界の前臨床毒性試験サービス市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の前臨床毒性試験サービス市場規模 世界の前臨床毒性試験サービス市場規模：2022年 VS 2029年 世界の前臨床毒性試験サービス市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの前臨床毒性試験サービスの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の前臨床毒性試験サービス製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：In Vitro毒性試験、In Vivo毒性試験 前臨床毒性試験サービスのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：バイオ製薬会社、研究所、その他 前臨床毒性試験サービスの用途別グローバル売上・予測 ・地域別市場分析 地域別前臨床毒性試験サービス市場規模 2022年と2029年 地域別前臨床毒性試験サービス売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Agilent、 Abbott、 Bio-Rad、 Scantox、 Charles River、 Bioreliance、 Catalent、 INVITEK Inc.、 Altogen Labs、 Pacific BioLabs、 AmplifyBio、 Altasciences、 Evotec、 Eurofins Scientific、 Pharmaron ... |
This research report provides a comprehensive analysis of the Preclinical Toxicology Testing Service market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Preclinical Toxicology Testing Service market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Preclinical Toxicology Testing Service, challenges faced by the industry, and potential opportunities for market players.
The global Preclinical Toxicology Testing Service market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Preclinical Toxicology Testing Service market presents opportunities for various stakeholders, including Biopharmaceutical Company, Research Laboratory. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Preclinical Toxicology Testing Service market. Additionally, the growing consumer demand present avenues for market expansion.
The global Preclinical Toxicology Testing Service market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
The global preclinical toxicology testing services market is significant and has experienced steady growth in recent years. It is driven by the continuous development of new pharmaceuticals, chemicals, and medical devices, as well as increasing regulatory scrutiny. The United States is a major hub for preclinical toxicology testing services, with a well-established pharmaceutical and biotechnology industry. Regulatory requirements from the FDA drive the demand for toxicology testing. Countries within the European Union also have significant demand for preclinical toxicology testing due to the robust pharmaceutical industry. Regulatory bodies like the European Medicines Agency (EMA) require safety assessments for market approval. The Asia-Pacific region is experiencing substantial growth in preclinical toxicology testing services, particularly in countries like China and India, where the pharmaceutical and chemical industries are expanding rapidly.
Key Features:
The research report on the Preclinical Toxicology Testing Service market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Preclinical Toxicology Testing Service market.
Market Overview: The report provides a comprehensive overview of the Preclinical Toxicology Testing Service market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., In Vitro Toxicology Testing, In Vivo Toxicology Testing), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Preclinical Toxicology Testing Service market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Preclinical Toxicology Testing Service market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Preclinical Toxicology Testing Service market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Preclinical Toxicology Testing Service market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Preclinical Toxicology Testing Service market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Preclinical Toxicology Testing Service market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Preclinical Toxicology Testing Service, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Preclinical Toxicology Testing Service market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Preclinical Toxicology Testing Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
In Vitro Toxicology Testing
In Vivo Toxicology Testing
Market segment by Application
Biopharmaceutical Company
Research Laboratory
Others
Global Preclinical Toxicology Testing Service Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East＆Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East＆Africa
Major players covered
Agilent
Abbott
Bio-Rad
Scantox
Charles River
Bioreliance
Catalent
INVITEK Inc.
Altogen Labs
Pacific BioLabs
AmplifyBio
Altasciences
Evotec
Eurofins Scientific
Pharmaron
Outline of Major Chapters:
Chapter 1: Introduces the definition of Preclinical Toxicology Testing Service, market overview.
Chapter 2: Global Preclinical Toxicology Testing Service market size in revenue.
Chapter 3: Detailed analysis of Preclinical Toxicology Testing Service company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Preclinical Toxicology Testing Service in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research＆Analysis Reports
1.1 Preclinical Toxicology Testing Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Preclinical Toxicology Testing Service Market Overview
1.4 Features＆Benefits of This Report
1.5 Methodology＆Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions＆Caveats
2 Global Preclinical Toxicology Testing Service Overall Market Size
2.1 Global Preclinical Toxicology Testing Service Market Size: 2022 VS 2029
2.2 Global Preclinical Toxicology Testing Service Market Size, Prospects＆Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities＆Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Preclinical Toxicology Testing Service Players in Global Market
3.2 Top Global Preclinical Toxicology Testing Service Companies Ranked by Revenue
3.3 Global Preclinical Toxicology Testing Service Revenue by Companies
3.4 Top 3 and Top 5 Preclinical Toxicology Testing Service Companies in Global Market, by Revenue in 2022
3.5 Global Companies Preclinical Toxicology Testing Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Preclinical Toxicology Testing Service Players in Global Market
3.6.1 List of Global Tier 1 Preclinical Toxicology Testing Service Companies
3.6.2 List of Global Tier 2 and Tier 3 Preclinical Toxicology Testing Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Preclinical Toxicology Testing Service Market Size Markets, 2022＆2029
4.1.2 In Vitro Toxicology Testing
4.1.3 In Vivo Toxicology Testing
4.2 By Type – Global Preclinical Toxicology Testing Service Revenue＆Forecasts
4.2.1 By Type – Global Preclinical Toxicology Testing Service Revenue, 2018-2023
4.2.2 By Type – Global Preclinical Toxicology Testing Service Revenue, 2024-2029
4.2.3 By Type – Global Preclinical Toxicology Testing Service Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Preclinical Toxicology Testing Service Market Size, 2022＆2029
5.1.2 Biopharmaceutical Company
5.1.3 Research Laboratory
5.1.4 Others
5.2 By Application – Global Preclinical Toxicology Testing Service Revenue＆Forecasts
5.2.1 By Application – Global Preclinical Toxicology Testing Service Revenue, 2018-2023
5.2.2 By Application – Global Preclinical Toxicology Testing Service Revenue, 2024-2029
5.2.3 By Application – Global Preclinical Toxicology Testing Service Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Preclinical Toxicology Testing Service Market Size, 2022＆2029
6.2 By Region – Global Preclinical Toxicology Testing Service Revenue＆Forecasts
6.2.1 By Region – Global Preclinical Toxicology Testing Service Revenue, 2018-2023
6.2.2 By Region – Global Preclinical Toxicology Testing Service Revenue, 2024-2029
6.2.3 By Region – Global Preclinical Toxicology Testing Service Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Preclinical Toxicology Testing Service Revenue, 2018-2029
6.3.2 US Preclinical Toxicology Testing Service Market Size, 2018-2029
6.3.3 Canada Preclinical Toxicology Testing Service Market Size, 2018-2029
6.3.4 Mexico Preclinical Toxicology Testing Service Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Preclinical Toxicology Testing Service Revenue, 2018-2029
6.4.2 Germany Preclinical Toxicology Testing Service Market Size, 2018-2029
6.4.3 France Preclinical Toxicology Testing Service Market Size, 2018-2029
6.4.4 U.K. Preclinical Toxicology Testing Service Market Size, 2018-2029
6.4.5 Italy Preclinical Toxicology Testing Service Market Size, 2018-2029
6.4.6 Russia Preclinical Toxicology Testing Service Market Size, 2018-2029
6.4.7 Nordic Countries Preclinical Toxicology Testing Service Market Size, 2018-2029
6.4.8 Benelux Preclinical Toxicology Testing Service Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Preclinical Toxicology Testing Service Revenue, 2018-2029
6.5.2 China Preclinical Toxicology Testing Service Market Size, 2018-2029
6.5.3 Japan Preclinical Toxicology Testing Service Market Size, 2018-2029
6.5.4 South Korea Preclinical Toxicology Testing Service Market Size, 2018-2029
6.5.5 Southeast Asia Preclinical Toxicology Testing Service Market Size, 2018-2029
6.5.6 India Preclinical Toxicology Testing Service Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Preclinical Toxicology Testing Service Revenue, 2018-2029
6.6.2 Brazil Preclinical Toxicology Testing Service Market Size, 2018-2029
6.6.3 Argentina Preclinical Toxicology Testing Service Market Size, 2018-2029
6.7 Middle East＆Africa
6.7.1 By Country – Middle East＆Africa Preclinical Toxicology Testing Service Revenue, 2018-2029
6.7.2 Turkey Preclinical Toxicology Testing Service Market Size, 2018-2029
6.7.3 Israel Preclinical Toxicology Testing Service Market Size, 2018-2029
6.7.4 Saudi Arabia Preclinical Toxicology Testing Service Market Size, 2018-2029
6.7.5 UAE Preclinical Toxicology Testing Service Market Size, 2018-2029
7 Preclinical Toxicology Testing Service Companies Profiles
7.1 Agilent
7.1.1 Agilent Company Summary
7.1.2 Agilent Business Overview
7.1.3 Agilent Preclinical Toxicology Testing Service Major Product Offerings
7.1.4 Agilent Preclinical Toxicology Testing Service Revenue in Global Market (2018-2023)
7.1.5 Agilent Key News＆Latest Developments
7.2 Abbott
7.2.1 Abbott Company Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Preclinical Toxicology Testing Service Major Product Offerings
7.2.4 Abbott Preclinical Toxicology Testing Service Revenue in Global Market (2018-2023)
7.2.5 Abbott Key News＆Latest Developments
7.3 Bio-Rad
7.3.1 Bio-Rad Company Summary
7.3.2 Bio-Rad Business Overview
7.3.3 Bio-Rad Preclinical Toxicology Testing Service Major Product Offerings
7.3.4 Bio-Rad Preclinical Toxicology Testing Service Revenue in Global Market (2018-2023)
7.3.5 Bio-Rad Key News＆Latest Developments
7.4 Scantox
7.4.1 Scantox Company Summary
7.4.2 Scantox Business Overview
7.4.3 Scantox Preclinical Toxicology Testing Service Major Product Offerings
7.4.4 Scantox Preclinical Toxicology Testing Service Revenue in Global Market (2018-2023)
7.4.5 Scantox Key News＆Latest Developments
7.5 Charles River
7.5.1 Charles River Company Summary
7.5.2 Charles River Business Overview
7.5.3 Charles River Preclinical Toxicology Testing Service Major Product Offerings
7.5.4 Charles River Preclinical Toxicology Testing Service Revenue in Global Market (2018-2023)
7.5.5 Charles River Key News＆Latest Developments
7.6 Bioreliance
7.6.1 Bioreliance Company Summary
7.6.2 Bioreliance Business Overview
7.6.3 Bioreliance Preclinical Toxicology Testing Service Major Product Offerings
7.6.4 Bioreliance Preclinical Toxicology Testing Service Revenue in Global Market (2018-2023)
7.6.5 Bioreliance Key News＆Latest Developments
7.7 Catalent
7.7.1 Catalent Company Summary
7.7.2 Catalent Business Overview
7.7.3 Catalent Preclinical Toxicology Testing Service Major Product Offerings
7.7.4 Catalent Preclinical Toxicology Testing Service Revenue in Global Market (2018-2023)
7.7.5 Catalent Key News＆Latest Developments
7.8 INVITEK Inc.
7.8.1 INVITEK Inc. Company Summary
7.8.2 INVITEK Inc. Business Overview
7.8.3 INVITEK Inc. Preclinical Toxicology Testing Service Major Product Offerings
7.8.4 INVITEK Inc. Preclinical Toxicology Testing Service Revenue in Global Market (2018-2023)
7.8.5 INVITEK Inc. Key News＆Latest Developments
7.9 Altogen Labs
7.9.1 Altogen Labs Company Summary
7.9.2 Altogen Labs Business Overview
7.9.3 Altogen Labs Preclinical Toxicology Testing Service Major Product Offerings
7.9.4 Altogen Labs Preclinical Toxicology Testing Service Revenue in Global Market (2018-2023)
7.9.5 Altogen Labs Key News＆Latest Developments
7.10 Pacific BioLabs
7.10.1 Pacific BioLabs Company Summary
7.10.2 Pacific BioLabs Business Overview
7.10.3 Pacific BioLabs Preclinical Toxicology Testing Service Major Product Offerings
7.10.4 Pacific BioLabs Preclinical Toxicology Testing Service Revenue in Global Market (2018-2023)
7.10.5 Pacific BioLabs Key News＆Latest Developments
7.11 AmplifyBio
7.11.1 AmplifyBio Company Summary
7.11.2 AmplifyBio Business Overview
7.11.3 AmplifyBio Preclinical Toxicology Testing Service Major Product Offerings
7.11.4 AmplifyBio Preclinical Toxicology Testing Service Revenue in Global Market (2018-2023)
7.11.5 AmplifyBio Key News＆Latest Developments
7.12 Altasciences
7.12.1 Altasciences Company Summary
7.12.2 Altasciences Business Overview
7.12.3 Altasciences Preclinical Toxicology Testing Service Major Product Offerings
7.12.4 Altasciences Preclinical Toxicology Testing Service Revenue in Global Market (2018-2023)
7.12.5 Altasciences Key News＆Latest Developments
7.13 Evotec
7.13.1 Evotec Company Summary
7.13.2 Evotec Business Overview
7.13.3 Evotec Preclinical Toxicology Testing Service Major Product Offerings
7.13.4 Evotec Preclinical Toxicology Testing Service Revenue in Global Market (2018-2023)
7.13.5 Evotec Key News＆Latest Developments
7.14 Eurofins Scientific
7.14.1 Eurofins Scientific Company Summary
7.14.2 Eurofins Scientific Business Overview
7.14.3 Eurofins Scientific Preclinical Toxicology Testing Service Major Product Offerings
7.14.4 Eurofins Scientific Preclinical Toxicology Testing Service Revenue in Global Market (2018-2023)
7.14.5 Eurofins Scientific Key News＆Latest Developments
7.15 Pharmaron
7.15.1 Pharmaron Company Summary
7.15.2 Pharmaron Business Overview
7.15.3 Pharmaron Preclinical Toxicology Testing Service Major Product Offerings
7.15.4 Pharmaron Preclinical Toxicology Testing Service Revenue in Global Market (2018-2023)
7.15.5 Pharmaron Key News＆Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
